AUGX:NSD-Augmedix, Inc. Common Stock (USD)

COMMON STOCK | Health Information Services | NSD

Last Closing Price

USD 3.46

Change

-0.02 (-0.57)%

Market Cap

USD 0.14B

Volume

0.07M

Avg Analyst Target

USD 7.50 (+116.76%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict


Augmedix, Inc. Common Stock (AUGX) Stock Analysis:
Based on the Augmedix, Inc. Common Stock stock forecasts from 3 analysts, the average analyst target price for Augmedix, Inc. Common Stock is USD 7.50 over the next 12 months. Augmedix, Inc. Common Stock’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Augmedix, Inc. Common Stock is Bearish, which is based on 1 positive signals and 4 negative signals. At the last closing, Augmedix, Inc. Common Stock’s stock price was USD 3.46. Augmedix, Inc. Common Stock’s stock price has changed by -0.14 % over the past week, -0.34 % over the past month and +0.00 % over the last year.

About

Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. It offers software that is compatible with off-the-shelf, mobile client devices, which enables clinicians to communicate with remotely located documentation spe ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-12-03 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
CERN Cerner Corporation

-0.20 (-0.28%)

USD20.73B 42.56 12.76
TXG 10x Genomics Inc

-10.50 (-7.07%)

USD16.14B N/A N/A
GDRX GoodRx Holdings Inc

-1.24 (-3.13%)

USD16.00B 927.27 238.21
OMCL Omnicell Inc

-2.19 (-1.24%)

USD7.78B 102.26 43.45
RCM R1 RCM Inc

-0.12 (-0.50%)

USD6.66B 72.63 31.03
CHNG Change Healthcare Inc

-0.44 (-2.12%)

USD6.40B N/A 13.92
INOV Inovalon Holdings Inc

N/A

USD6.37B 122.57 33.93
HQY HealthEquity Inc

-2.34 (-4.13%)

USD4.79B 6,216.56 36.06
PINC Premier Inc

+0.51 (+1.38%)

USD4.69B 17.41 11.15
PGNY Progyny Inc

-1.30 (-2.65%)

USD4.62B 52.79 128.47

ETFs Containing AUGX

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Health Information Services)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 0.14B 23% F 27% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Health Information Services)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio 24.96 6% F 5% F
Price / Cash Flow Ratio -9.47 60% D- 73% C
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A N/A N/A
Return on Invested Capital 0.08% 58% F 53% F
Return on Assets -75.50% 3% F 2% F
Debt to Equity Ratio 266.95% 10% F 7% F
Technical Ratios  
Short Ratio 0.01 97% A+ 99% A+
Short Percent 0.01% 100% A+ 100% A+
Beta N/A N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.